Xiao Feng Selected Research

lapiferin

1/2020

Lapiferin protects against H1N1 virus-induced pulmonary inflammation by negatively regulating NF-kB signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Feng Research Topics

Disease

35	Neoplasms (Cancer) 06/2022 - 05/2002
8	Carcinogenesis 06/2022 - 01/2013
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2017
8	Neoplasm Metastasis (Metastasis) 06/2021 - 01/2011
8	Macular Degeneration (Age-Related Maculopathy) 11/2008 - 02/2004
6	Inflammation (Inflammations) 04/2022 - 03/2007
4	Reperfusion Injury 01/2021 - 01/2016
4	Infarction (Infarctions) 01/2020 - 01/2016
4	Colorectal Neoplasms (Colorectal Cancer) 05/2015 - 01/2012
3	Hypoxia (Hypoxemia) 09/2020 - 01/2019
3	Edema (Dropsy) 01/2019 - 07/2017
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 01/2016
3	Ulcerative Colitis 01/2017 - 01/2012
2	Adenocarcinoma of Lung 06/2022 - 01/2022
2	Synovial Sarcoma (Synovioma) 02/2022 - 01/2021
2	Infections 01/2022 - 01/2020
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 10/2021
2	Nervous System Diseases (Neurological Disorders) 10/2021 - 01/2018
2	Communicable Diseases (Infectious Diseases) 03/2021 - 07/2017
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2012
2	Fibrosis (Cirrhosis) 01/2021 - 07/2015
2	Glioma (Gliomas) 09/2020 - 01/2017
2	Melanoma (Melanoma, Malignant) 09/2020 - 03/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2019 - 01/2018
2	Heart Diseases (Heart Disease) 01/2019 - 11/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 01/2017
2	Pain (Aches) 03/2017 - 03/2012
2	Colitis 01/2017 - 03/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 04/2014
2	Ischemia 05/2016 - 01/2016
2	Spinal Cord Injuries (Spinal Cord Injury) 07/2012 - 02/2009
2	Choroidal Effusions 07/2011 - 11/2006
1	Lung Neoplasms (Lung Cancer) 06/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2022
1	Diarrhea 03/2022
1	Stroke (Strokes) 03/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Nevus (Nevi) 01/2022
1	Cerebral Hemorrhage 12/2021
1	Immune System Diseases (Immune Disorders) 10/2021
1	Osteonecrosis (Kienbock's Disease) 05/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2021
1	Carcinoma (Carcinomatosis) 01/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
13	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2012
8	Caspase 3 (Caspase-3)IBA 01/2019 - 05/2015
7	Pharmaceutical PreparationsIBA 01/2020 - 11/2006
5	Messenger RNA (mRNA)IBA 01/2021 - 01/2012
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
4	LipidsIBA 04/2022 - 08/2007
4	Retinaldehyde (Retinal)IBA 11/2008 - 07/2006
3	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2017
3	HMGB1 Protein (HMG1)IBA 01/2021 - 05/2015
3	Long Noncoding RNAIBA 03/2020 - 01/2019
3	NF-kappa B (NF-kB)IBA 01/2020 - 01/2012
3	Metformin (Glucophage)FDA LinkGeneric 12/2019 - 01/2017
3	Phosphotransferases (Kinase)IBA 12/2019 - 01/2012
3	CholesterolIBA 11/2019 - 11/2008
3	Therapeutic UsesIBA 01/2019 - 01/2014
3	Adenosine A3 ReceptorIBA 01/2017 - 01/2014
2	Inosine Triphosphate (ITP)IBA 01/2022 - 10/2021
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2019 - 01/2018
2	MB Form Creatine KinaseIBA 01/2019 - 11/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2017
2	ElementsIBA 01/2019 - 12/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019 - 01/2016
2	Levonorgestrel (Plan B)FDA LinkGeneric 01/2019 - 03/2012
2	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 08/2007
2	Eukaryotic Initiation Factor-4EIBA 01/2017 - 05/2016
2	pterostilbeneIBA 01/2017 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2016 - 01/2014
2	ThapsigarginIBA 01/2016 - 01/2016
2	2- chloro- N(6)- (3- iodobenzyl)adenosine- 5'- N- methyluronamideIBA 03/2015 - 01/2014
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2013 - 04/2013
2	TensinsIBA 12/2013 - 04/2013
2	AntibodiesIBA 05/2009 - 02/2006
2	Monoclonal AntibodiesIBA 02/2006 - 05/2002
1	EphA5 ReceptorIBA 06/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2022
1	QuercetinIBA 04/2022
1	Triglycerides (Triacylglycerol)IBA 03/2022
1	SYT-SSX fusion proteinIBA 02/2022
1	EphA7 ReceptorIBA 01/2022
1	Eph Family Receptors (Eph Receptors)IBA 01/2022
1	CytokinesIBA 01/2022
1	Drug CarriersIBA 01/2022
1	PhosphotyrosineIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021
1	ACHN-975IBA 03/2021

Therapy/Procedure

8	Therapeutics 01/2022 - 06/2006
7	Drug Therapy (Chemotherapy) 06/2021 - 11/2006
6	Radiotherapy 01/2021 - 10/2015
3	Liver Transplantation 01/2022 - 05/2019
2	Hip Replacement Arthroplasty (Total Hip Replacement) 05/2021 - 01/2020
2	Tibetan Traditional Medicine (Traditional Tibetan Medicine) 08/2020 - 07/2017
2	Injections 01/2020 - 07/2011
1	Length of Stay 03/2022